Literature DB >> 14595521

Identification of sentinel lymph nodes in colon cancer depends on the amount of dye injected relative to tumor size.

Carsten T Viehl1, Christian T Hamel, Walter R Marti, Ulrich Guller, Lukas Eisner, Uz Stammberger, Luigi Terracciano, Hans P Spichtin, Felix Harder, Markus Zuber.   

Abstract

Recent studies have shown that the sentinel lymph node (SLN) procedure might improve staging in colon cancer. However, low SLN identification and high false negative rates have also been reported. In a two-institution study, the SLN procedure with isosulfan blue 1% was performed according to a standardized protocol in 31 patients with open resections for colon cancer. Data were collected prospectively. The database was analyzed retrospectively to determine factors contributing to a low identification rate. The SLN identification rate was 87% and the false negative rate was 50%. Successful SLN identification was significantly associated with application of higher volumes of dye relative to the tumor diameter ( p = 0.04) and more frequent tumor localization in the sigmoid colon ( p = 0.04) as compared to missing SLN identification. The tumor diameter was not significantly different in the two groups. Sentinel lymph node identification in colon cancer depends on the amount of dye injected relative to the tumor size. Application of only 1 ml of dye-the amount generally recommended in the literature-is not sufficient in large tumors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14595521     DOI: 10.1007/s00268-003-7086-5

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  26 in total

1.  Lymphatic mapping of nodal micrometastasis in colon cancer: putting the cart before the horse?

Authors:  Anton J Bilchik; Dean T Nora
Journal:  Ann Surg Oncol       Date:  2002-07       Impact factor: 5.344

2.  Validation of sentinel node mapping in patients with colon cancer.

Authors:  Juan C Paramo; Janna Summerall; Robert Poppiti; Thomas W Mesko
Journal:  Ann Surg Oncol       Date:  2002-07       Impact factor: 5.344

Review 3.  Adjuvant therapy for colorectal cancer.

Authors:  A M Cohen; D Kelsen; L Saltz; B D Minsky; H Nelson; R Farouk; L L Gunderson; F Michelassi; R B Arenas; R L Schilsky; C G Willet
Journal:  Curr Probl Surg       Date:  1997-08       Impact factor: 1.909

4.  The role of sentinel lymph node mapping in staging of colon and rectal cancer.

Authors:  S Esser; W T Reilly; L B Riley; C Eyvazzadeh; S Arcona
Journal:  Dis Colon Rectum       Date:  2001-06       Impact factor: 4.585

5.  The role of the sentinel lymph node in gastrointestinal cancer.

Authors:  Y Kitagawa; H Fujii; M Mukai; T Kubota; N Ando; M Watanabe; M Ohgami; Y Otani; S Ozawa; H Hasegawa; T Furukawa; K Kumai; T Ikeda; T Nakahara; A Kubo; M Kitajima
Journal:  Surg Clin North Am       Date:  2000-12       Impact factor: 2.741

6.  Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins.

Authors:  R Cutait; V A Alves; L C Lopes; D E Cutait; J L Borges; J Singer; J H da Silva; F S Goffi
Journal:  Dis Colon Rectum       Date:  1991-10       Impact factor: 4.585

7.  Lymph node micrometastases do not predict relapse in stage II colon cancer.

Authors:  J Tschmelitsch; D S Klimstra; A M Cohen
Journal:  Ann Surg Oncol       Date:  2000-09       Impact factor: 5.344

Review 8.  Micrometastasis in colorectal carcinoma: a review.

Authors:  R Calaluce; B W Miedema; Y W Yesus
Journal:  J Surg Oncol       Date:  1998-03       Impact factor: 3.454

9.  Technical details of sentinel lymph node mapping in colorectal cancer and its impact on staging.

Authors:  S Saha; D Wiese; J Badin; T Beutler; D Nora; B K Ganatra; D Desai; S Kaushal; M Nagaraju; M Arora; T Singh
Journal:  Ann Surg Oncol       Date:  2000-03       Impact factor: 5.344

10.  A caution regarding lymphatic mapping in patients with colon cancer.

Authors:  B W Feig; S Curley; A Lucci; K K Hunt; J N Vauthey; P F Mansfield; K Cleary; S Hamilton; V Ellis; M Brame; D H Berger
Journal:  Am J Surg       Date:  2001-12       Impact factor: 2.565

View more
  18 in total

1.  Blue dye injection does not induce dissemination of epithelial cells during SLN procedure in colon cancer patients.

Authors:  Hannes J Larusson; Urs von Holzen; Carsten T Viehl; Farid Rezaeian; Hans-Martin Riehle; Daniel Oertli; Ulrich Guller; Markus Zuber
Journal:  Int J Colorectal Dis       Date:  2014-04-25       Impact factor: 2.571

2.  Sentinel Lymph Node Mapping with Isosulfan Blue or Indocyanine Green in Colon Cancer Shows Comparable Results and Identifies Patients with Decreased Survival: A Prospective Single-Center Trial.

Authors:  Benjamin Weixler; Andreas Rickenbacher; Dimitri Aristotle Raptis; Carsten T Viehl; Ulrich Guller; Jessica Rueff; Andreas Zettl; Markus Zuber
Journal:  World J Surg       Date:  2017-09       Impact factor: 3.352

3.  Analysis of sentinel lymph node biopsy results in colon cancer in regard of the anthropometric features of the population and body composition assessment formulas.

Authors:  Piotr Nowaczyk; Dawid Murawa; Karol Połom; Magdalena Waszyk-Nowaczyk; Arkadiusz Spychała; Michał Michalak; Paweł Murawa
Journal:  Langenbecks Arch Surg       Date:  2012-03-14       Impact factor: 3.445

4.  Intranodal Mapping Using Carbon Dye Results in More Accurate Lymph Node Staging in Colon Cancer Patients.

Authors:  Benjamin Weixler; Rene Warschkow; Andreas Zettl; Hans-Martin Riehle; Ulrich Guller; Carsten T Viehl; Markus Zuber
Journal:  World J Surg       Date:  2015-10       Impact factor: 3.352

5.  Laparoscopic lymphatic mapping and sentinel lymph node detection in colon cancer: technical aspects and preliminary results.

Authors:  Paolo Pietro Bianchi; Chiara Ceriani; Matteo Rottoli; Guido Torzilli; Massimo Roncalli; Antonino Spinelli; Marco Montorsi
Journal:  Surg Endosc       Date:  2007-02-07       Impact factor: 4.584

6.  Factors influencing the success of in vivo sentinel lymph node procedure in colon cancer patients: Swiss prospective, multicenter study sentinel lymph node procedure in colon cancer.

Authors:  Carsten T Viehl; Ulrich Guller; Igor Langer; Urban Laffer; Daniel Oertli; Markus Zuber
Journal:  World J Surg       Date:  2013-04       Impact factor: 3.352

7.  [Sentinel lymph node biopsy in colorectal carcinoma].

Authors:  A Bembenek; S Gretschel; C Ulmer; P M Schlag
Journal:  Chirurg       Date:  2004-08       Impact factor: 0.955

8.  Carbon dye staining of sentinel lymph nodes facilitates microstaging of colon cancer patients.

Authors:  Carsten T Viehl; Ulrich Guller; Christian T Hamel; Hans-Martin Riehle; Christian Plaass; Walter R Marti; Daniel Oertli; Markus Zuber
Journal:  World J Surg       Date:  2006-03       Impact factor: 3.352

9.  Prospective randomized study comparing sentinel lymph node evaluation with standard pathologic evaluation for the staging of colon carcinoma: results from the United States Military Cancer Institute Clinical Trials Group Study GI-01.

Authors:  Alexander Stojadinovic; Aviram Nissan; Mladjan Protic; Carol F Adair; Diana Prus; Slavica Usaj; Robin S Howard; Dragan Radovanovic; Milan Breberina; Craig D Shriver; Ronit Grinbaum; Jeffery M Nelson; Tommy A Brown; Herbert R Freund; John F Potter; Tamar Peretz; George E Peoples
Journal:  Ann Surg       Date:  2007-06       Impact factor: 12.969

Review 10.  What's wrong with sentinel node mapping in colon cancer?

Authors:  Ronan A Cahill
Journal:  World J Gastroenterol       Date:  2007-12-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.